Fresenius reported €471M in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Akzo Nobel AKZA:NA € 261M 44M
Alcon AG ALC:SW 151M 67M
AstraZeneca AZN:LN 550M 1011M
BASF BAS:GR € 1654M 64M
Bayer BAYN:GR € -2335M 4424M
Davita Healthcare Partners DVA:US $ 293.82M 56.42M
DSM DSM:NA € 56M 126M
E.ON EOAN:GR 1.75B 946M
Fresenius FRE:GR € 471M 36M
Fresenius Medical Care FME:GR € 219M 30M
Getinge GETIB:SS SK 797M 153M
Givaudan GIVN:VX 481M 151M
GlaxoSmithKline GSK:LN 1395M 322M
GN Store Nord GN:DC DK 427M 47M
GRIFOLS GRF:SM € 136.88M 6.94M
Hikma Pharmaceutical HIK:LN 248M 29M
Lonza Group LONN:SW 319M 73M
Merck MRK:GR € 745M 2M
Novartis NOVN:VX SF 2896M 837M
Philips PHIA:NA € 151M 113M
RWE RWE:GR € 537M 358M
William Demant Holding WDH:DC 1.17B 172M